Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1036

1.

Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.

Castelli G, Fornaro A, Ciaccheri M, Dolara A, Troiani V, Tomberli B, Olivotto I, Gensini GF.

Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.

2.

Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.

Hamada T, Kubo T, Kitaoka H, Hirota T, Hoshikawa E, Hayato K, Shimizu Y, Okawa M, Yamasaki N, Matsumura Y, Yabe T, Takata J, Doi YL.

Clin Cardiol. 2010 Jul;33(7):E24-8. doi: 10.1002/clc.20533.

3.

Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.

Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A, Sinagra G.

Eur J Heart Fail. 2014 Mar;16(3):317-24. doi: 10.1002/ejhf.16. Epub 2013 Dec 14.

4.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

5.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.

6.

Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.

Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.

Am J Cardiol. 2011 Apr 1;107(7):1065-70. doi: 10.1016/j.amjcard.2010.11.033. Epub 2011 Feb 4.

PMID:
21296328
7.

Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.

Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, Bussani R, Silvestri F, Iorio AM, Stolfo D, Dal Ferro M, Dragos AM, Meringolo G, Pyxaras S, Lo Giudice F, Perkan A, di Lenarda A, Sinagra G.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):699-705. doi: 10.2459/JCM.0b013e32832bba35.

PMID:
19474760
8.

Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.

Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, Emdin M, Lombardi M.

Circ Cardiovasc Imaging. 2013 Sep;6(5):790-9. doi: 10.1161/CIRCIMAGING.113.000438. Epub 2013 Aug 9.

9.

Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy.

Broch K, Murbræch K, Andreassen AK, Hopp E, Aakhus S, Gullestad L.

Am J Cardiol. 2015 Sep 15;116(6):952-9. doi: 10.1016/j.amjcard.2015.06.022. Epub 2015 Jun 25.

PMID:
26233575
10.

How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".

Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.

Am J Cardiol. 2012 Mar 1;109(5):729-35. doi: 10.1016/j.amjcard.2011.10.033. Epub 2011 Dec 15.

PMID:
22176998
11.

Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.

Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, Romito R, Iacoviello M, De Tommasi E, Troisi F, Rizzon B, Guanti G, Rizzon P, Pitzalis MV.

Am J Med. 2004 Oct 1;117(7):451-8.

PMID:
15464701
12.

Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy.

Dini FL, Cortigiani L, Baldini U, Boni A, Nuti R, Barsotti L, Micheli G.

Am J Cardiol. 2002 Mar 1;89(5):518-23.

PMID:
11867034
13.

Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.

Juillière Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F.

Eur Heart J. 1997 Feb;18(2):276-80.

PMID:
9043845
14.
15.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

N Engl J Med. 2004 May 20;350(21):2151-8.

16.

Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.

Bobbo M, Pinamonti B, Merlo M, Stolfo D, Iorio A, Ramani F, Barbati G, Carriere C, Massa L, Poli S, Scapol S, Gigli M, Di Lenarda A, Sinagra G.

Am J Cardiol. 2017 Feb 1;119(3):483-489. doi: 10.1016/j.amjcard.2016.10.014. Epub 2016 Nov 11.

PMID:
27988039
17.

Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.

Hamada M, Hara Y, Ohtsuka T, Suzuki J, Saeki H, Ogimoto A, Shigematsu Y.

J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S5-10.

PMID:
12688389
18.

Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.

Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC.

Circ Res. 2013 Jan 4;112(1):165-73. doi: 10.1161/CIRCRESAHA.112.276519. Epub 2012 Oct 12.

19.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

20.

Outcomes of children following a first hospitalization for dilated cardiomyopathy.

Hollander SA, Bernstein D, Yeh J, Dao D, Sun HY, Rosenthal D.

Circ Heart Fail. 2012 Jul 1;5(4):437-43. doi: 10.1161/CIRCHEARTFAILURE.111.964510. Epub 2012 May 8.

Supplemental Content

Support Center